Clinical Trials | April 15, 2024
Teva confirms efficacy and safety of Ajovy for prevention of migraine
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
WINREVAIR is a breakthrough biologic for this rare, progressive disease
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
_Rupak_Singla_256_384.jpg)
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
iSolveSM information on demand is the result of our focus on customer relationship
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Subscribe To Our Newsletter & Stay Updated
